CN107287256B - Method for synthesizing L-2-piperidinecarboxylic acid by whole-cell catalysis - Google Patents

Method for synthesizing L-2-piperidinecarboxylic acid by whole-cell catalysis Download PDF

Info

Publication number
CN107287256B
CN107287256B CN201610196785.3A CN201610196785A CN107287256B CN 107287256 B CN107287256 B CN 107287256B CN 201610196785 A CN201610196785 A CN 201610196785A CN 107287256 B CN107287256 B CN 107287256B
Authority
CN
China
Prior art keywords
ala
leu
val
recombinant host
piperidinecarboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610196785.3A
Other languages
Chinese (zh)
Other versions
CN107287256A (en
Inventor
朱惠霖
丁雪峰
陈令伟
娄向弟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Nuoyun Biotechnology Co ltd
Original Assignee
Nanjing Nuoyun Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Nuoyun Biotechnology Co ltd filed Critical Nanjing Nuoyun Biotechnology Co ltd
Priority to CN201610196785.3A priority Critical patent/CN107287256B/en
Publication of CN107287256A publication Critical patent/CN107287256A/en
Application granted granted Critical
Publication of CN107287256B publication Critical patent/CN107287256B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • C12P17/12Nitrogen as only ring hetero atom containing a six-membered hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention belongs to the technical field of biocatalysis, and particularly relates to a method for synthesizing L-2-piperidinecarboxylic acid by whole-cell catalysis. The method for synthesizing the L-2-piperidinecarboxylic acid by whole-cell biocatalysis disclosed by the invention is characterized in that L-lysine hydrochloride is used as a substrate, and L-2-piperidinecarboxylic acid is prepared by biocatalysis by adding nicotinamide adenine dinucleotide and a recombinant host bacterium containing an Arenimonas donghaensis DSM 18148 protein encoding gene, or a recombinant host bacterium containing a Pseudomonas veronii CIP104663 protein encoding gene or a recombinant host bacterium containing a Streptomyces hirsutus ATCC 19091 protein encoding gene. Thereby overcoming the problems of high cost, rigorous conditions, low conversion rate, high energy consumption and large pollution of the existing chemical synthesis method. Meanwhile, the biological catalysis system disclosed by the invention has the advantages of high enzyme activity efficiency, short reaction time and high ee value of the target product.

Description

Method for synthesizing L-2-piperidinecarboxylic acid by whole-cell catalysis
Technical Field
The invention belongs to the technical field of biocatalysis, and particularly relates to a method for synthesizing L-2-piperidinecarboxylic acid by whole-cell catalysis.
Background
The L-2-piperidinecarboxylic acid is a naturally-occurring non-protein amino acid, is an important chiral drug intermediate, can be used for preparing rapamycin, an antitumor agent VX-710, an immunosuppressant FK506, piperidine alkaloid and the like, and has high industrial application value. The existing main production method is chemical synthesis and has the defects of low yield, high energy consumption, high pollution and the like. While the ee value is difficult to control.
Fujii et al accumulated 3.9g/L of the product in 159 hours using an engineered E.coli strain that recombinantly expressed L-lysine-6-aminotransferase and dihydropyrrole-5-carboxylate reductase. Subsequent additions of lysP lysine permease and yeiE resulted in a maximum accumulation of 16g/L at 111 hours. The scheme has the main problems of overlong reaction time, too little product generation amount, too high actual production cost and difficulty in scale-up production.
Yasushi Tani et al realizes the conversion from DL-lysine to L-2-piperidinecarboxylic acid by coexpressing four proteins, namely LysR, rAIP, DpkA, GDH and the like, and the conversion rate of the product reaches 87.4% in 46 hours, but the disadvantages of great difficulty in strain construction, poor repeatability and the like exist in the coexpression of a plurality of proteins.
Ying and the like utilize escherichia coli containing a pipA gene as a whole-cell catalyst, and optimize NAD concentration, reaction temperature, reaction pH, addition of metal ions, addition of an expression active agent and the like, so that the final product can reach 17.25 g/L. The low pipA enzyme activity in this protocol resulted in the use of an excess of whole cells (OD 200), low substrate concentration (lysine 25g/L) and required batch additions of substrate to complete the reaction. These factors lead to problems such as excessive cost in scale-up production.
Disclosure of Invention
In view of the problems in the prior art, the invention aims to develop a high-efficiency biocatalytic system, so as to improve the substrate dosage, shorten the reaction time and obtain a product with a high ee value.
In order to achieve the above object, the invention adopts the following technical scheme:
a method for synthesizing L-2-piperidinecarboxylic acid by whole-cell biocatalysis comprises taking L-lysine hydrochloride or L-lysine as substrate, adding nicotinamide adenine dinucleotide and recombinant host bacteria, and preparing L-2-piperidinecarboxylic acid by biocatalysis; wherein the recombinant host bacterium is any one of a recombinant host bacterium containing an Arenimonas donghaensis DSM 18148 protein encoding gene, a recombinant host bacterium containing a Pseudomonas veronii CIP104663 protein encoding gene or a recombinant host bacterium containing a Streptomyces hirsutus ATCC 19091 protein encoding gene. Wherein the recombinant host bacterium is Escherichia coli.
Further, the reaction was carried out in a pH8.0 potassium phosphate buffer solution.
Preferably, the reaction temperature is from 20 ℃ to 30 ℃.
Also, we preferably disclose that the reaction is carried out on a shaker at a shaker speed of 180 rpm.
Finally, we disclose wherein the concentration of the recombinant host bacterium is from 50g/L to 150 g/L.
The method for synthesizing the L-2-piperidinecarboxylic acid by whole-cell catalysis disclosed by the invention overcomes the problems of high cost, harsh conditions, low conversion rate, high energy consumption and large pollution of the conventional chemical synthesis method. Meanwhile, the biological catalysis system disclosed by the invention has the advantages of high enzyme activity efficiency, short reaction time and high ee value of the target product.
Drawings
FIG. 1 is an expression plasmid map of NYPDC
FIG. 2 is SDS-PAGE patterns of protein expression supernatant and inclusion bodies of NYPDa, NYPDB, NYPDC, NYPDD and NYPDE
FIG. 3 is a TLC chart of the biotransformation reaction in example 8
FIG. 4 is an HPLC chromatogram of L-2-piperidinecarboxylic acid in example 8
FIG. 5 is a MS spectrum of L-2-piperidinecarboxylic acid of example 8
FIG. 6 is an expression plasmid map of SEQ ID NO.10
FIG. 7 is an SDS-PAGE pattern of E.coli containing the expression plasmid of SEQ ID NO. 10.
FIG. 8 is a TLC pattern of the biotransformation reaction in example 15
FIG. 9 is an HPLC chromatogram of L-2-piperidinecarboxylic acid in example 15
FIG. 10 is a MS spectrum of L-2-piperidinecarboxylic acid of example 15
FIG. 11 is an expression plasmid map of SEQ ID NO.13
FIG. 12 is an SDS-PAGE pattern of E.coli containing the expression plasmid of SEQ ID NO. 13.
FIG. 13 is a TLC pattern of the biotransformation reaction of example 19
FIG. 14 is an HPLC chromatogram of L-2-piperidinecarboxylic acid in example 19
FIG. 15 is a MS spectrum of L-2-piperidinecarboxylic acid of example 19
Detailed Description
In order to better explain the invention, the invention is further illustrated below with reference to examples. The instruments and reagents used in the present examples are commercially available products unless otherwise specified.
In the TLC assays referred to in the following examples:
developing agent: trichloromethane: methanol: mixing water at ratio of 6:5:1, standing for about 10 min.
Specification of the silica gel plate: thin layer chromatography silica gel plate 5x 10.
Color developing agent: ninhydrin coloration 100ml ethanol add 0.1g ninhydrin, 500ul glacial acetic acid and mix.
The LC-MS detection conditions referred to in the following examples are:
a Prevail C18 column (250X 4.6mm, i.d.5 μm); column temperature: 30 ℃; mobile phase: 0.4% (v/v) aqueous trifluoroacetic acid; flow rate: 0.5 ml/min; a detector: evaporative Light Scattering Detector (ELSD); detector temperature: 120 ℃; carrier gas: nitrogen (purity 99.9%); flow rate of carrier gas: 4L/min; sample introduction volume: 10 μ L.
Example 1
The Arenimonas donghaensis DSM 18148 was placed in LB medium, incubated at 30 ℃ and 180rpm for 3-5 days, the precipitate was collected by centrifugation, and the purified Arenimonas donghaensis DSM 18148 DNA was extracted using the DNA extraction and purification Kit Qiaamp Kit (Qiagen, Germany).
The genomic DNA of Arenimonas donghaensis DSM 18148 was PCR amplified with Pfu high fidelity enzyme using primers
NYPD-F 5' ATGACCATGACCCAGCTCACCA 3'
NYPD-R 5' TCAGGCCGCCTGCTTGC 3'
Since the GC content of the Arenimonas donghaensis DSM 18148 DNA fragment was close to 70%, betaine was added at a final concentration of 0.5M during amplification. Then, the amplified fragment was treated with Taq polymerase at 72 ℃ for 10 minutes to add base A to the 3' end of the DNA. This was then ligated into the pMD19T-simple (Takara Bao Bio Inc., Beijing) cloning vector, and a single clone was picked and sent to the Shanghai organism for sequencing. The DNA sequence obtained by sequencing is SEQ ID NO.1, and the corresponding amino acid sequence is SEQ ID NO. 2.
Example 2
Because the GC content of the original DNA sequence is too high, efficient transcription is difficult to realize during culture in host bacteria. Therefore, the secondary structure and codon preference of the gene are adjusted by a whole-gene synthesis method so as to realize high expression in Escherichia coli. The following primers were obtained by designing using Primer Premier (http:// Primer3.ut. ee /) and OPTIMIZER (http:// genes. urv. es/OPTIMIZER /) with the Tm difference controlled to be within 3 ℃ and the Primer length controlled to be within 50 base:
Figure BDA0000955204360000031
Figure BDA0000955204360000041
the above primers were synthesized, and the obtained primers were dissolved in double distilled water and added to the following reaction system so that the final concentration of each primer was 30nM and the final concentration of the head and tail primers was 0.6. mu.M.
2mM dNTP mix(2mM each dNTP) 5μl
10×Pfu buffer 5μl
Pfu DNA polymerase(10U/μl) 0.5μl
ddH2O The total volume of the reaction system was adjusted to 50. mu.l
The prepared PCR reaction system is placed in a Bori XP cycler gene amplification instrument and amplified according to the following procedures: 30s at 98 ℃, 45s at 55 ℃, 120s at 72 ℃ and 35 x. The DNA fragment obtained by PCR was purified by gel cutting and cloned into the NdeI/XhoI site of pET30a by homologous recombination. Single clones were picked for sequencing. The DNA sequence successfully sequenced is SEQ ID NO.3 and is named NYPDA.
An expression plasmid containing NYPDA was constructed in the manner described with reference to FIG. 1.
Example 3
The secondary structure and codon preference of the gene are adjusted by a whole-gene synthesis method so as to realize high expression in escherichia coli. The following primers were obtained by designing using Primer Premier (http:// Primer3.ut. ee /) and OPTIMIZER (http:// genes. urv. es/OPTIMIZER /) with the Tm difference controlled to be within 3 ℃ and the Primer length controlled to be within 50 base:
Figure BDA0000955204360000051
Figure BDA0000955204360000061
the above primers were synthesized, and the obtained primers were dissolved in double distilled water and added to the following reaction system so that the final concentration of each primer was 30nM and the final concentration of the head and tail primers was 0.6. mu.M.
2mM dNTP mix(2mM each dNTP) 5μl
10×Pfu buffer 5μl
Pfu DNA polymerase(10U/μl) 0.5μl
ddH2O The total volume of the reaction system was adjusted to 50. mu.l
The prepared PCR reaction system is placed in a Bori XP cycler gene amplification instrument and amplified according to the following procedures: 30s at 98 ℃, 45s at 55 ℃, 120s at 72 ℃ and 35 x. The DNA fragment obtained by PCR was purified by gel cutting and cloned into the NdeI/XhoI site of pET30a by homologous recombination. Single clones were picked for sequencing. The DNA sequence successfully sequenced is SEQ ID NO.4 and is named NYPDB.
An expression plasmid containing NYPDB was constructed in the manner described with reference to FIG. 1.
Example 4
The secondary structure and codon preference of the gene are adjusted by a whole-gene synthesis method so as to realize high expression in escherichia coli. The following primers were obtained by designing using Primer Premier (http:// Primer3.ut. ee /) and OPTIMIZER (http:// genes. urv. es/OPTIMIZER /) with the Tm difference controlled to be within 3 ℃ and the Primer length controlled to be within 50 base:
Figure BDA0000955204360000062
Figure BDA0000955204360000071
the above primers were synthesized, and the obtained primers were dissolved in double distilled water and added to the following reaction system so that the final concentration of each primer was 30nM and the final concentration of the head and tail primers was 0.6. mu.M.
2mM dNTP mix(2mM each dNTP) 5μl
10×Pfu buffer 5μl
Pfu DNA polymerase(10U/μl) 0.5μl
ddH2O The total volume of the reaction system was adjusted to 50. mu.l
The prepared PCR reaction system is placed in a Bori XP cycler gene amplification instrument and amplified according to the following procedures: 30s at 98 ℃, 45s at 55 ℃, 120s at 72 ℃ and 35 x. The DNA fragment obtained by PCR was purified by gel cutting and cloned into the NdeI/XhoI site of pET30a by homologous recombination. Single clones were picked for sequencing. The DNA sequence successfully sequenced is SEQ ID NO.5 and is named NYPDC.
Expression plasmids containing NYPDC were constructed in the manner shown in FIG. 1.
Example 5
The secondary structure and codon preference of the gene are adjusted by a whole-gene synthesis method so as to realize high expression in escherichia coli. The following primers were obtained by designing using Primer Premier (http:// Primer3.ut. ee /) and OPTIMIZER (http:// genes. urv. es/OPTIMIZER /) with the Tm difference controlled to be within 3 ℃ and the Primer length controlled to be within 50 base:
Figure BDA0000955204360000081
Figure BDA0000955204360000091
the above primers were synthesized, and the obtained primers were dissolved in double distilled water and added to the following reaction system so that the final concentration of each primer was 30nM and the final concentration of the head and tail primers was 0.6. mu.M.
2mM dNTP mix(2mM each dNTP) 5μl
10×Pfu buffer 5μl
Pfu DNA polymerase(10U/μl) 0.5μl
ddH2O The total volume of the reaction system was adjusted to 50. mu.l
The prepared PCR reaction system is placed in a Bori XP cycler gene amplification instrument and amplified according to the following procedures: 30s at 98 ℃, 45s at 55 ℃, 120s at 72 ℃ and 35 x. The DNA fragment obtained by PCR was purified by gel cutting and cloned into the NdeI/XhoI site of pET30a by homologous recombination. Single clones were picked for sequencing. The DNA sequence successfully sequenced is SEQ ID NO.6 and is named NYPDD.
An expression plasmid containing NYPDD was constructed in the manner described with reference to FIG. 1.
Example 6
The secondary structure and codon preference of the gene are adjusted by a whole-gene synthesis method so as to realize high expression in escherichia coli. The following primers were obtained by designing using Primer Premier (http:// Primer3.ut. ee /) and OPTIMIZER (http:// genes. urv. es/OPTIMIZER /) with the Tm difference controlled to be within 3 ℃ and the Primer length controlled to be within 50 base:
Figure BDA0000955204360000092
Figure BDA0000955204360000101
the above primers were synthesized, and the obtained primers were dissolved in double distilled water and added to the following reaction system so that the final concentration of each primer was 30nM and the final concentration of the head and tail primers was 0.6. mu.M.
2mM dNTP mix(2mM each dNTP) 5μl
10×Pfu buffer 5μl
Pfu DNA polymerase(10U/μl) 0.5μl
ddH2O The total volume of the reaction system was adjusted to 50. mu.l
The prepared PCR reaction system is placed in a Bori XP cycler gene amplification instrument and amplified according to the following procedures: 30s at 98 ℃, 45s at 55 ℃, 120s at 72 ℃ and 35 x. The DNA fragment obtained by PCR was purified by gel cutting and cloned into the NdeI/XhoI site of pET30a by homologous recombination. Single clones were picked for sequencing. The DNA sequence successfully sequenced is SEQ ID NO.7 and is named NYPDE.
An expression plasmid containing NYPDE was constructed in the manner described with reference to FIG. 1.
Example 7
And E.coli single colony containing NYPDA expression vector is selected and inoculated in 10ml of culture medium after autoclaving: 10g/L tryptone, 5g/L yeast extract, 3.55g/L disodium hydrogen phosphate, 3.4g/L potassium dihydrogen phosphate, 2.68g/L ammonium chloride, 0.71g/L sodium sulfate, 0.493g/L magnesium sulfate heptahydrate, 0.027g/L ferric chloride hexahydrate, 5g/L glycerol, 0.8g/L glucose, and kanamycin to 50 mg/L. The culture was carried out at 30 ℃ and 250rpm overnight. Taking a 1L triangular flask the next day, and carrying out the following steps: 100 into 100ml of autoclaved medium: 10g/L tryptone, 5g/L yeast extract, 3.55g/L disodium hydrogen phosphate, 3.4g/L potassium dihydrogen phosphate, 2.68g/L ammonium chloride, 0.71g/L sodium sulfate, 0.493g/L magnesium sulfate heptahydrate, 0.027g/L ferric chloride hexahydrate, 5g/L glycerol, 0.3g/L glucose, and kanamycin to 50 mg/L. The cells were cultured at 30 ℃ until the OD 5-6 of the cells became zero, and the cells were immediately placed in a flask in a shaker at 25 ℃ and cultured at 250rpm for 1 hour. IPTG was added to a final concentration of 0.1mM and incubation was continued at 25 ℃ for 16 hours at 250 rpm. After completion of the culture, the culture was centrifuged at 12000g at 4 ℃ for 20 minutes to collect wet cells. Then the bacterial pellet is washed twice with distilled water, and the bacterial is collected and preserved at-70 ℃. Meanwhile, a small amount of thallus is taken for SDS-PAGE detection.
According to the above method, thallus of NYPDB, NYPDC, NYPDD, NYPDE were prepared respectively and subjected to SDS-PAGE protein gel detection, and the results are shown in FIG. 2. SDS-PAGE protein gel shows that NYPDC has the highest expression level, so that it is used as the preferred sequence for subsequent experiment.
Example 8
0.1M potassium phosphate buffer (pH8.0), 150g/L NYPDC cells, 25g/L L-lysine hydrochloride, 0.1mM NAD were added thereto, and the mixture was subjected to an open reaction at 25 ℃ with the rotation speed of the shaker set at 180 rpm. The sample was continuously taken out for TLC detection, and when the reaction time was 16 hours, the detection result is shown in FIG. 3, and the result shows that a large amount of product was produced in 16 hours, and no residue remained. The samples were simultaneously sampled and subjected to LC-MS detection, and the detection results are shown in FIG. 4 and FIG. 5.
Example 9
0.1M potassium phosphate buffer (pH8.0), 50g/L NYPDC cells, 74g/L L-lysine hydrochloride, 0.1mM NAD were added thereto, and the mixture was subjected to an open reaction at 25 ℃ with the rotation speed of the shaker set at 180 rpm. The reaction was sampled continuously for TLC detection, and the results showed that a large amount of product was produced in 48 hours with no residue. Meanwhile, sampling and carrying out LC-MS detection, and determining that the concentration of the final product reaches 37 g/L.
Example 10
0.1M potassium phosphate buffer (pH8.0), 50g/L NYPDC cells, 100g/L L-lysine hydrochloride, 0.1mM NAD were added thereto, and the mixture was subjected to an open reaction at 25 ℃ with the rotation speed of the shaker set at 180 rpm. The reaction was sampled continuously for TLC detection, and the results showed that a large amount of product was produced in 48 hours with no residue. Meanwhile, sampling and carrying out LC-MS detection, and determining that the concentration of the final product reaches 66.7 g/L.
Example 11
0.1M potassium phosphate buffer (pH8.0), 50g/L NYPDC cells, 150g/L L-lysine hydrochloride, 0.1mM NAD were added thereto, and the mixture was subjected to an open reaction at 25 ℃ with the rotation speed of the shaker set at 180 rpm. The reaction was sampled continuously for TLC detection, and the results showed that a large amount of product was produced in 48 hours with no residue. Meanwhile, sampling and carrying out LC-MS detection, and determining that the concentration of the final product reaches 76.9 g/L.
Example 12
Pseudomonas veronii CIP104663 was cultured in LB medium at 28.0 ℃ for 3 days at 180rpm, and the precipitate was collected by centrifugation, and purified Pseudomonas veronii genomic DNA was extracted using the DNA extraction and purification Kit Qiaamp Kit (Qiagen, Germany).
Carrying out PCR amplification on Pseudomonas veronii genome DNA by Pfu high fidelity enzyme, wherein the primer is
Pve-F 5' ATGGTGGCACAGCGAGCAAC 3'
Pve-R 5' TCATGCTAATTTTAAGGTACGGTCG 3'
Since the GC content of DNA of Pseudomonas veronii CIP104663 was close to 50%, it was directly amplified using Pfu high fidelity enzyme. Then, the amplified fragment was treated with Taq polymerase at 72 ℃ for 10 minutes to add base A to the 3' end of the DNA. This was then ligated into a pMD19T-simple (Takara Bao Bio Inc., Beijing) cloning vector, and single clones were picked up and sent to Nanjing Kinsry organisms for sequencing. The DNA sequence obtained by sequencing is SEQ ID NO.8, and the corresponding amino acid sequence is SEQ ID NO. 9.
Example 13
The secondary structure and codon preference of the gene are adjusted by a whole-gene synthesis method, and the GC content of the DNA sequence is adjusted to 40-60 percent so as to realize high expression in Escherichia coli. The following primers were obtained by designing using Primer Premier (http:// Primer3.ut. ee /) and OPTIMIZER (http:// genes. urv. es/OPTIMIZER /) with the Tm difference controlled to be within 3 ℃ and the Primer length controlled to be within 50 base:
Figure BDA0000955204360000121
Figure BDA0000955204360000131
Figure BDA0000955204360000141
the above primers were synthesized, and the obtained primers were dissolved in double distilled water and added to the following reaction system so that the final concentration of each primer was 30nM and the final concentration of the head and tail primers was 0.6. mu.M.
2mM dNTP mix(2mM each dNTP) 5μl
10×Pfu buffer 5μl
Pfu DNA polymerase(10 U/μl) 0.5μl
ddH2O The total volume of the reaction system was adjusted to 50. mu.l
The prepared PCR reaction system is placed in a Bori XP cycler gene amplification instrument and amplified according to the following procedures: 30s at 98 ℃, 45s at 65 ℃, 120s at 72 ℃ and 35 x. The DNA fragment obtained by PCR was purified by gel cutting and cloned into the NdeI/XhoI site of pET30a by homologous recombination. Single clones were picked for sequencing. The DNA sequence successfully sequenced is SEQ ID NO. 10.
An expression plasmid containing SEQ ID NO.10 was constructed in the manner shown in FIG. 6.
Example 14
Selecting a single escherichia coli colony containing an expression vector of SEQ ID NO.10 and inoculating the single escherichia coli colony in 10ml of an autoclaved culture medium: 10g/L tryptone, 5g/L yeast extract, 3.55g/L disodium hydrogen phosphate, 3.4g/L potassium dihydrogen phosphate, 2.68g/L ammonium chloride, 0.71g/L sodium sulfate, 0.493g/L magnesium sulfate heptahydrate, 0.027g/L ferric chloride hexahydrate, 5g/L glycerol, 0.8g/L glucose, and kanamycin to 50 mg/L. The culture was carried out at 30 ℃ and 250rpm overnight. Taking a 1L triangular flask the next day, and carrying out the following steps: 100 into 100ml of autoclaved medium: 10g/L tryptone, 5g/L yeast extract, 3.55g/L disodium hydrogen phosphate, 3.4g/L potassium dihydrogen phosphate, 2.68g/L ammonium chloride, 0.71g/L sodium sulfate, 0.493g/L magnesium sulfate heptahydrate, 0.027g/L ferric chloride hexahydrate, 5g/L glycerol, 0.3g/L glucose, and kanamycin to 50 mg/L. The cells were cultured at 30 ℃ until the OD 5-6 of the cells became zero, and the cells were immediately placed in a flask in a shaker at 25 ℃ and cultured at 250rpm for 1 hour. IPTG was added to a final concentration of 0.1mM and incubation was continued at 25 ℃ for 16 hours at 250 rpm. After completion of the culture, the culture was centrifuged at 12000g at 4 ℃ for 20 minutes to collect wet cells. Then the bacterial pellet is washed twice with distilled water, and the bacterial is collected and preserved at-70 ℃. Meanwhile, a small amount of thallus is taken for SDS-PAGE detection.
The results are shown in FIG. 7, in which lane 1 is the protein supernatant and lane 2 is the inclusion body. SDS-PAGE albumen glue shows that the expression quantity of the Escherichia coli containing the expression plasmid of SEQ ID NO.10 is high, and the requirements of biotransformation reaction experiments are met.
Example 15
0.1M potassium phosphate buffer (pH8.0), 65g/L of the cells containing the expression plasmid of SEQ ID NO.10, 60g/L L-lysine hydrochloride, 0.1mM NAD, were added to the mixture, and the reaction was opened to the atmosphere at 25 ℃ with the shaking table rotating at 180 rpm. The sample was continuously taken out for TLC detection, and when the reaction time was 16 hours, the detection result is shown in FIG. 8, and the result shows that a large amount of product was produced in 28 hours, and no residue remained. The product obtained was subjected to quantitative experiments and the final concentration of the product was 48.7 g/L. The samples were simultaneously sampled and subjected to LC-MS detection, and the detection results are shown in FIGS. 9 and 10.
Example 16
Streptomyces hirsutus ATCC 19091 was cultured in ATCC Medium 196 for 2 days at 180rpm at a temperature of 26.0 ℃ under centrifugation, and the precipitate was collected by centrifugation, and genomic DNA of Streptomyces hirsutus ATCC 19091 was extracted and purified using the DNA extraction and purification Kit Qiaamp Kit (Qiagen, Germany).
PCR amplification of Streptomyces hirsutus ATCC 19091 genomic DNA with Pfu Hi-Fi enzyme
Shi-F 5' ATCTTGCAAGCTGAGCGCACG 3'
Shi-R 5' TCATCGTCGCGCTCCGGC 3'
Since the local GC content of the DNA of Streptomyces hirsutus ATCC 19091 was close to 80%, betaine was added at a final concentration of 0.5M during amplification. Then, the amplified fragment was treated with Taq polymerase at 72 ℃ for 10 minutes to add base A to the 3' end of the DNA. This was then ligated into the pMD19T-simple (Takara Bao Bio Inc., Beijing) cloning vector, and a single clone was picked and sent to the Shanghai Jie plum organism for sequencing. The DNA sequence obtained by sequencing is SEQ ID NO.11, and the corresponding amino acid sequence is SEQ ID NO. 12.
Example 17
The secondary structure and codon preference of the gene are adjusted by a whole-gene synthesis method, and the GC content of the DNA sequence is adjusted to 40-60 percent so as to realize high expression in Escherichia coli. The following primers were obtained by designing using Primer Premier (http:// Primer3.ut. ee /) and OPTIMIZER (http:// genes. urv. es/OPTIMIZER /) with the Tm difference controlled to be within 3 ℃ and the Primer length controlled to be within 50 base:
Figure BDA0000955204360000151
Figure BDA0000955204360000161
the above primers were synthesized, and the obtained primers were dissolved in double distilled water and added to the following reaction system so that the final concentration of each primer was 30nM and the final concentration of the head and tail primers was 0.6. mu.M.
2mM dNTP mix(2mM each dNTP) 5μl
10×Pfu buffer 5μl
Pfu DNA polymerase(10U/μl) 0.5μl
ddH2O The total volume of the reaction system was adjusted to 50. mu.l
The prepared PCR reaction system is placed in a Bori XP cycler gene amplification instrument and amplified according to the following procedures: 30s at 98 ℃, 45s at 65 ℃, 120s at 72 ℃ and 35 x. The DNA fragment obtained by PCR was purified by gel cutting and cloned into the NdeI/XhoI site of pET30a by homologous recombination. Single clones were picked for sequencing. The DNA sequence successfully sequenced is SEQ ID NO. 13.
An expression plasmid containing SEQ ID NO.13 was constructed in the manner shown in FIG. 11.
Example 18
The single colony of Escherichia coli containing the expression vector of SEQ ID NO.13 was selected and inoculated into 10ml of autoclaved medium: 10g/L tryptone, 5g/L yeast extract, 3.55g/L disodium hydrogen phosphate, 3.4g/L potassium dihydrogen phosphate, 2.68g/L ammonium chloride, 0.71g/L sodium sulfate, 0.493g/L magnesium sulfate heptahydrate, 0.027g/L ferric chloride hexahydrate, 5g/L glycerol, 0.8g/L glucose, and kanamycin to 50 mg/L. The culture was carried out at 30 ℃ and 250rpm overnight. Taking a 1L triangular flask the next day, and carrying out the following steps: 100 into 100ml of autoclaved medium: 10g/L tryptone, 5g/L yeast extract, 3.55g/L disodium hydrogen phosphate, 3.4g/L potassium dihydrogen phosphate, 2.68g/L ammonium chloride, 0.71g/L sodium sulfate, 0.493g/L magnesium sulfate heptahydrate, 0.027g/L ferric chloride hexahydrate, 5g/L glycerol, 0.3g/L glucose, and kanamycin to 50 mg/L. The cells were cultured at 30 ℃ until the OD 5-6 of the cells became zero, and the cells were immediately placed in a flask in a shaker at 25 ℃ and cultured at 250rpm for 1 hour. IPTG was added to a final concentration of 0.1mM and incubation was continued at 25 ℃ for 16 hours at 250 rpm. After completion of the culture, the culture was centrifuged at 12000g at 4 ℃ for 20 minutes to collect wet cells. Then the bacterial pellet is washed twice with distilled water, and the bacterial is collected and preserved at-70 ℃. Meanwhile, a small amount of thallus is taken for SDS-PAGE detection.
The results are shown in FIG. 12, in which lane 1 is the protein supernatant and lane 2 is the inclusion body. SDS-PAGE albumen glue shows that the expression quantity of the Escherichia coli containing the expression plasmid of SEQ ID NO.13 is high, and the requirements of biotransformation reaction experiments are met.
Example 19
0.1M potassium phosphate buffer (pH8.0), 50g/L of the cells containing the expression plasmid of SEQ ID NO.13, 55g/L L-lysine hydrochloride, 0.1mM NAD were added, and the reaction was opened to the atmosphere at 25 ℃ with the shaking table rotating at 180 rpm. The sample was continuously taken out for TLC detection, and when the reaction time was 16 hours, the detection result is shown in FIG. 13, and the result shows that a large amount of product was produced in 16 hours, and no residue remained. The product obtained was subjected to quantitative experiments and had a final concentration of 32 g/L. The samples were simultaneously sampled and subjected to LC-MS detection, and the detection results are shown in FIG. 14 and FIG. 15.
When L-lysine was added to the system, it was rapidly converted to L-lysine hydrochloride, and then the reaction was carried out in the same manner as in the previous example.
By using the novel enzyme protein of the present invention, the optimized gene sequence, and the optimized transformation process, L-2-piperidinecarboxylic acid, which is an industrially useful compound as a pharmaceutical intermediate, can be efficiently produced, and the process is simple and the yield is high. The substrate used for conversion is L-lysine which is industrially produced in large quantity, the price is low, the quotation of 98 percent content lysine is about 8.5-8.6 yuan/kg according to the domestic lysine market quotation in 2016 and 1 month, and the domestic yield can reach 120 tons only, thereby ensuring the sufficient supply of the substrate. The technology has strong portability, can be put into production only in a common fermentation workshop (such as an amino acid and vitamin production workshop), does not need to purchase special equipment, and is easy to popularize and apply. Compared with the current domestic production which mainly depends on a chemical resolution method, 50 percent of raw materials are resolved and wasted, a large amount of useless byproducts are generated, and the ee value of the product is lower. Therefore, the invention has stronger practicability and popularization value.
SEQUENCE LISTING
<110> Nanjing Nuo cloud Biotechnology Ltd
<120> method for synthesizing L-2-piperidinecarboxylic acid by whole-cell catalysis
<130> 2016
<160> 13
<170> PatentIn version 3.3
<210> 1
<211> 1053
<212> DNA
<213> Arenimonas donghaensis
<400> 1
atgaccatga cccagctcac cacccaggac ctgacccaga tcgtcgcgac ccacggcctg 60
ccgaccctgc tcggccgcct ggtggactac ctggaggccg acttccggcg ctgggaggac 120
ttcgacaaga gcccgcgttc ggcggcccac tccccgggcg gcgtgatcga actgatgccg 180
gtcgccgata ccaaggaata cagcttcaag tacgtcaacg gccacccggg caacaccaag 240
ctgggcctgt ccaccgtggt ggccttcggc gtgctcgccg acgtcgatac cggcatgccg 300
accctgatca gcgaactgac cctgaccacc gcgctgcgca ccgccgccac ctcggtgatg 360
gcggccaagc tgctggcgcg caaggattcc aggaccatgg cgctgatcgg caacggcgcc 420
cagagcgagt tccaggcgct ggccttccac cacctgctgg gcatccagga agtgcgtgtg 480
tacgacgtcg acccggccgc caccgacaag ctggtgcgca acctggccgc ggccgcgccg 540
gaactgcgcg tggtgcgcag caccggcgtc gcccaggccg tgcgcggcgc cgacatcgtc 600
accaccgtca ccgcggacaa ggccaatgcc gacatcctga cgccggaaat gatcgagccg 660
ggcatgcacc tcaacgccgt cggcggcgac tgcccgggca agaccgaact ggccacggag 720
gtggtcgcca acgcctcggt gttcgtcgag ttcgagccgc agtcgcgcat cgaaggcgag 780
gtgcagcaga tgcccgccaa ctccccggtc accgaactgt ggcgcgtgct gaccatgcag 840
gccgccggcc gccgcaacat cgccgaggtc accctgttcg actcggtcgg tttcgcgctg 900
gaggattatt cggcgctgcg cctggtgcgc gattgcgcca aggaaatggg cctgggccgc 960
gaagccagcc tcatccccgc cctggccgac ccgaagaacc tgttcggcga gctggccgcg 1020
gcaccccagg ccgcgcgcaa gcaggcggcc tga 1053
<210> 2
<211> 350
<212> PRT
<213> Arenimonas donghaensis
<400> 2
Met Thr Met Thr Gln Leu Thr Thr Gln Asp Leu Thr Gln Ile Val Ala
1 5 10 15
Thr His Gly Leu Pro Thr Leu Leu Gly Arg Leu Val Asp Tyr Leu Glu
20 25 30
Ala Asp Phe Arg Arg Trp Glu Asp Phe Asp Lys Ser Pro Arg Ser Ala
35 40 45
Ala His Ser Pro Gly Gly Val Ile Glu Leu Met Pro Val Ala Asp Thr
50 55 60
Lys Glu Tyr Ser Phe Lys Tyr Val Asn Gly His Pro Gly Asn Thr Lys
65 70 75 80
Leu Gly Leu Ser Thr Val Val Ala Phe Gly Val Leu Ala Asp Val Asp
85 90 95
Thr Gly Met Pro Thr Leu Ile Ser Glu Leu Thr Leu Thr Thr Ala Leu
100 105 110
Arg Thr Ala Ala Thr Ser Val Met Ala Ala Lys Leu Leu Ala Arg Lys
115 120 125
Asp Ser Arg Thr Met Ala Leu Ile Gly Asn Gly Ala Gln Ser Glu Phe
130 135 140
Gln Ala Leu Ala Phe His His Leu Leu Gly Ile Gln Glu Val Arg Val
145 150 155 160
Tyr Asp Val Asp Pro Ala Ala Thr Asp Lys Leu Val Arg Asn Leu Ala
165 170 175
Ala Ala Ala Pro Glu Leu Arg Val Val Arg Ser Thr Gly Val Ala Gln
180 185 190
Ala Val Arg Gly Ala Asp Ile Val Thr Thr Val Thr Ala Asp Lys Ala
195 200 205
Asn Ala Asp Ile Leu Thr Pro Glu Met Ile Glu Pro Gly Met His Leu
210 215 220
Asn Ala Val Gly Gly Asp Cys Pro Gly Lys Thr Glu Leu Ala Thr Glu
225 230 235 240
Val Val Ala Asn Ala Ser Val Phe Val Glu Phe Glu Pro Gln Ser Arg
245 250 255
Ile Glu Gly Glu Val Gln Gln Met Pro Ala Asn Ser Pro Val Thr Glu
260 265 270
Leu Trp Arg Val Leu Thr Met Gln Ala Ala Gly Arg Arg Asn Ile Ala
275 280 285
Glu Val Thr Leu Phe Asp Ser Val Gly Phe Ala Leu Glu Asp Tyr Ser
290 295 300
Ala Leu Arg Leu Val Arg Asp Cys Ala Lys Glu Met Gly Leu Gly Arg
305 310 315 320
Glu Ala Ser Leu Ile Pro Ala Leu Ala Asp Pro Lys Asn Leu Phe Gly
325 330 335
Glu Leu Ala Ala Ala Pro Gln Ala Ala Arg Lys Gln Ala Ala
340 345 350
<210> 3
<211> 1053
<212> DNA
<213> Artificial sequence
<400> 3
atgaccatga cccagctgac cacccaggac ctgacccaga tcgttgctac ccacggtctg 60
ccgaccctgc tgggtcgtct ggttgactac ctggaagctg acttccgtcg ttgggaagac 120
ttcgacaaat ctccgcgttc tgctgctcac tctccgggtg gtgttatcga actgatgccg 180
gttgctgaca ccaaagaata ctctttcaaa tacgttaacg gtcacccggg taacaccaaa 240
ctgggtctgt ctaccgttgt tgctttcggt gttctggctg acgttgacac cggtatgccg 300
accctgatct ctgaactgac cctgaccacc gctctgcgta ccgctgctac ctctgttatg 360
gctgctaaac tgctggctcg taaagactct cgtaccatgg ctctgatcgg taacggtgct 420
cagtctgaat tccaggctct ggctttccac cacctgctgg gtatccagga agttcgtgtt 480
tacgacgttg acccggctgc taccgacaaa ctggttcgta acctggctgc tgctgctccg 540
gaactgcgtg ttgttcgttc taccggtgtt gctcaggctg ttcgtggtgc tgacatcgtt 600
accaccgtta ccgctgacaa agctaacgct gacatcctga ccccggaaat gatcgaaccg 660
ggtatgcacc tgaacgctgt tggtggtgac tgcccgggta aaaccgaact ggctaccgaa 720
gttgttgcta acgcttctgt tttcgttgaa ttcgaaccgc agtctcgtat cgaaggtgaa 780
gttcagcaga tgccggctaa ctctccggtt accgaactgt ggcgtgttct gaccatgcag 840
gctgctggtc gtcgtaacat cgctgaagtt accctgttcg actctgttgg tttcgctctg 900
gaagactact ctgctctgcg tctggttcgt gactgcgcta aagaaatggg tctgggtcgt 960
gaagcttctc tgatcccggc tctggctgac ccgaaaaacc tgttcggtga actggctgct 1020
gctccgcagg ctgctcgtaa acaggctgct taa 1053
<210> 4
<211> 1053
<212> DNA
<213> Artificial sequence
<400> 4
atgactatga ctcaactgac tactcaagac ctcactcaga ttgttgctac ccatggtctc 60
ccaaccctgc tcggtcgtct ggttgactat ctcgaagcgg acttccgccg ttgggaagac 120
ttcgacaagt ccccacgttc tgctgctcac tctccaggcg gtgttattga actcatgccg 180
gttgcggaca ccaaagaata ctctttcaaa tacgtgaacg gtcacccggg caataccaaa 240
ctcggtctct ctactgttgt tgcgttcggt gttctcgcgg atgttgacac tggtatgcca 300
actctcatct ctgagctgac cctgaccact gcgctccgta ccgctgcgac ttctgttatg 360
gcggcgaaac tgctggcgcg taaagactct cgtaccatgg ctctgatcgg taatggtgcg 420
cagtccgaat ttcaagcgct ggctttccac cacctgctgg gtatccagga agttcgtgtg 480
tacgacgtgg acccagcggc gactgataaa ctggttcgta acctggcggc tgctgcgcca 540
gaactgcgcg ttgttcgttc taccggtgtt gctcaagcgg tgcgtggcgc tgatatcgtt 600
actaccgtta ccgcggacaa ggcgaacgct gacatcctga ccccggaaat gatcgaaccg 660
ggtatgcacc tgaatgcggt tggtggtgat tgtccgggta aaactgaact ggcgaccgaa 720
gtggttgcga atgcgtctgt ttttgtggaa tttgaaccgc agtctcgtat cgaaggtgaa 780
gttcagcaaa tgccggcgaa ctccccagtt accgagctgt ggcgtgttct gaccatgcag 840
gctgcgggtc gtcgtaacat cgcggaggtt accctctttg attctgttgg tttcgctctg 900
gaggactatt ccgcgctgcg tctcgttcgc gattgcgcga aagaaatggg tctcggccgt 960
gaggcttccc tcattccagc tctggcggac ccgaaaaatc tgtttggtga actcgctgcg 1020
gctccacaag ctgctcgcaa acaggcggcg taa 1053
<210> 5
<211> 1053
<212> DNA
<213> Artificial sequence
<400> 5
atgaccatga cccagctgac cacccaggat ctgacccaga tcgttgcgac ccacggtctg 60
ccgaccctgc tgggccgtct ggttgactac ctggaagcgg acttccgtcg ttgggaagat 120
ttcgacaaat ctccgcgttc tgcggcgcac tctccgggtg gcgttatcga actgatgccg 180
gttgcggata ccaaagaata ctctttcaaa tatgttaacg gtcacccggg caacaccaaa 240
ctgggcctgt ctaccgttgt tgcgttcggc gttctggcgg atgttgacac cggtatgccg 300
accctgatct ctgaactgac cctgaccacc gcgctgcgta ccgcggcgac ctctgttatg 360
gcggcgaaac tgctggcgcg taaagactct cgtaccatgg cgctgatcgg caacggtgcg 420
cagtctgaat tccaggcgct ggcgttccac cacctgctgg gtatccagga agttcgtgtt 480
tatgacgttg atccggcggc gaccgataaa ctggttcgta acctggcggc ggcggcgccg 540
gaactgcgtg ttgttcgttc taccggtgtt gcgcaggcgg ttcgtggtgc ggacatcgtt 600
accaccgtta ccgcggacaa agcgaacgcg gatatcctga ccccggaaat gatcgaaccg 660
ggtatgcacc tgaacgcggt tggtggcgac tgtccgggta aaaccgaact ggcgaccgaa 720
gttgttgcga acgcgtctgt tttcgttgaa ttcgaaccgc agtctcgtat cgaaggcgaa 780
gttcagcaga tgccggcgaa ctctccggtt accgaactgt ggcgtgttct gaccatgcag 840
gcggcgggtc gtcgtaacat cgcggaagtt accctgttcg attctgttgg tttcgcgctg 900
gaagactatt ctgcgctgcg tctggttcgt gattgtgcga aagaaatggg cctgggtcgt 960
gaagcgtctc tgatcccggc gctggcggac ccgaaaaacc tgttcggtga actggcggcg 1020
gcgccgcagg cggcgcgtaa acaggcggcg taa 1053
<210> 6
<211> 1053
<212> DNA
<213> Artificial sequence
<400> 6
atgaccatga cccagctgac tactcaggac ctgactcaga tcgttgctac ccacggtctg 60
ccgactctgc tgggccgtct ggtggattac ctggaagcgg acttccgtcg ctgggaagac 120
tttgacaaat ccccgcgctc cgcggctcat tctccgggtg gtgttatcga actgatgccg 180
gttgcggaca ccaaagaata ctctttcaaa tacgtgaacg gtcacccggg caacactaaa 240
ctgggtctgt ccaccgtggt tgcgtttggc gttctggctg atgtggatac tggtatgccg 300
accctgatct ctgaactgac tctgaccacc gctctgcgta ccgctgctac ttctgttatg 360
gcggcgaaac tgctggctcg caaagactct cgtaccatgg cgctgatcgg caacggcgct 420
cagtctgaat ttcaggctct ggcttttcat cacctgctgg gtatccagga agttcgtgtg 480
tacgacgttg acccggctgc gaccgacaaa ctggttcgca acctggcggc tgctgctccg 540
gaactgcgtg tggttcgttc taccggtgtg gctcaggctg tgcgtggtgc ggatattgtt 600
accactgtta ccgcggacaa agcgaacgct gatatcctga ccccggaaat gatcgaaccg 660
ggcatgcacc tgaacgcggt tggtggtgat tgtccgggta aaaccgaact ggcgactgaa 720
gttgttgcta acgcgtccgt gtttgttgaa tttgaaccgc agtcccgcat cgaaggtgaa 780
gttcagcaga tgccggcgaa ctccccggtt actgaactgt ggcgtgttct gactatgcag 840
gcggctggcc gtcgtaacat cgcggaagtt actctgttcg attctgtggg cttcgctctg 900
gaagattatt ctgcgctgcg cctggtgcgc gactgtgcga aagaaatggg cctgggtcgt 960
gaagcgtccc tgattccggc gctggcggac ccgaaaaacc tgttcggtga actggctgcg 1020
gctccgcagg ctgcgcgtaa acaggctgct taa 1053
<210> 7
<211> 1053
<212> DNA
<213> Artificial sequence
<400> 7
atgactatga cccaactgac tactcaggac ctgactcaga tcgttgcgac ccacggcctg 60
ccgaccctgc tgggccgtct ggtagactac ctggaagcgg acttccgtcg ttgggaagac 120
tttgacaaat ctccgcgttc tgcggcgcac tccccgggtg gcgttatcga actgatgccg 180
gtagcggata ccaaggaata ctctttcaaa tatgttaacg gtcatccggg caacaccaaa 240
ctgggtctgt ctaccgtagt agcgttcggt gttctggcgg acgttgacac tggtatgccg 300
actctgatta gcgagctgac cctgaccacc gcgctgcgta ccgcggcaac ctctgtaatg 360
gcggcaaaac tgctggcgcg caaagactct cgtaccatgg cgctgatcgg caacggtgcg 420
caatctgaat tccaagcgct ggcgttccac catctgctgg gtatccagga ggttcgtgtt 480
tatgacgtgg acccggcagc gaccgataaa ctggttcgta atctggctgc ggctgcaccg 540
gaactgcgcg tagttcgttc tactggcgtg gctcaggctg tgcgtggtgc ggacattgtt 600
accaccgtta ccgctgacaa agcgaacgca gatatcctga ccccggaaat gattgagccg 660
ggtatgcatc tgaacgctgt aggtggtgac tgcccgggta aaaccgagct ggcaactgaa 720
gtggttgcta atgcgtctgt tttcgttgaa ttcgaaccgc agtctcgtat cgaaggcgaa 780
gttcagcaaa tgccggctaa ctctccggtt actgagctgt ggcgtgtact gaccatgcag 840
gcagctggtc gccgtaacat cgcggaagtt accctgtttg acagcgtagg tttcgcactg 900
gaagattatt ctgcactgcg cctggtgcgc gactgtgcaa aagaaatggg cctgggtcgt 960
gaggcaagcc tgatcccggc actggctgat ccgaaaaacc tgttcggcga actggcagcg 1020
gctccgcagg ctgctcgcaa acaagcggca taa 1053
<210> 8
<211> 1116
<212> DNA
<213> Pseudomonas veronii
<400> 8
atggtggcac agcgagcaac tattatcctc tctgaggaaa acattggtga aattgtcgca 60
gcagtcgggc tcgacacttt aatggatgaa acgattgcaa aactacgtga tgccctcaac 120
gtgtttggtg atggccaggt tgaaatacaa ccgcgcaccg gctttgtcta tgaaactccg 180
gaaatggggc tgatagagtt tatgccggct taccgccggg ataaaaatgt cgcgttaaaa 240
gttgttggct accatccggg aaatccgttt aaccggggca tgccgacggt catcgccact 300
aactccctat atgacgtaag ggacggccac cttattgcgg tgatcgatgg tgtatttgca 360
acagcagtac gaacgggcgc agcatccgct gtggcttcga agttgctggc tcatcctgaa 420
agcaaaaccc ttgggctgat cggagctggc gccatggcag tgacccaggc ccatgccctc 480
agtcgaattt atgactttga cgcagtcttg atccacgata ttgaccccgc agtggaaaaa 540
actttcgcca agcgggtatc cgccctggga attacaccga tcatcgcttc caaagacagg 600
gtactggcag agtccgacat catctgtgtt gctacctcca ttggccttga tgcaggcccg 660
gttctccacg ctggcgggat gaaaccacat gtacacatca atgctattgg tgccgacacg 720
ccgcgcaaat atgaattatc aacagagctg ctcaaaagct cgttccttgt cacggattat 780
ctggaacagg ccattaacga aggtgaatgc cagcaattga gtaaagacga atacggctat 840
atcggccctg agttgcacaa aatagtgaaa gagccgcaag cctatatcca atatcagatg 900
aaacagacca tctttgatag caccggtatt tcattggaag atcagataat gaccgaggtc 960
ttgatcgatc aggcggagag actagggctt ggtcagcgga tcctgattga agcgggatgt 1020
gatgacccca tgaacccata tcttttctca aattccgcga acgctcttga taccgtcaag 1080
aatacagtgc acgaccgtac cttaaaatta gcatga 1116
<210> 9
<211> 371
<212> PRT
<213> Pseudomonas veronii
<400> 9
Met Val Ala Gln Arg Ala Thr Ile Ile Leu Ser Glu Glu Asn Ile Gly
1 5 10 15
Glu Ile Val Ala Ala Val Gly Leu Asp Thr Leu Met Asp Glu Thr Ile
20 25 30
Ala Lys Leu Arg Asp Ala Leu Asn Val Phe Gly Asp Gly Gln Val Glu
35 40 45
Ile Gln Pro Arg Thr Gly Phe Val Tyr Glu Thr Pro Glu Met Gly Leu
50 55 60
Ile Glu Phe Met Pro Ala Tyr Arg Arg Asp Lys Asn Val Ala Leu Lys
65 70 75 80
Val Val Gly Tyr His Pro Gly Asn Pro Phe Asn Arg Gly Met Pro Thr
85 90 95
Val Ile Ala Thr Asn Ser Leu Tyr Asp Val Arg Asp Gly His Leu Ile
100 105 110
Ala Val Ile Asp Gly Val Phe Ala Thr Ala Val Arg Thr Gly Ala Ala
115 120 125
Ser Ala Val Ala Ser Lys Leu Leu Ala His Pro Glu Ser Lys Thr Leu
130 135 140
Gly Leu Ile Gly Ala Gly Ala Met Ala Val Thr Gln Ala His Ala Leu
145 150 155 160
Ser Arg Ile Tyr Asp Phe Asp Ala Val Leu Ile His Asp Ile Asp Pro
165 170 175
Ala Val Glu Lys Thr Phe Ala Lys Arg Val Ser Ala Leu Gly Ile Thr
180 185 190
Pro Ile Ile Ala Ser Lys Asp Arg Val Leu Ala Glu Ser Asp Ile Ile
195 200 205
Cys Val Ala Thr Ser Ile Gly Leu Asp Ala Gly Pro Val Leu His Ala
210 215 220
Gly Gly Met Lys Pro His Val His Ile Asn Ala Ile Gly Ala Asp Thr
225 230 235 240
Pro Arg Lys Tyr Glu Leu Ser Thr Glu Leu Leu Lys Ser Ser Phe Leu
245 250 255
Val Thr Asp Tyr Leu Glu Gln Ala Ile Asn Glu Gly Glu Cys Gln Gln
260 265 270
Leu Ser Lys Asp Glu Tyr Gly Tyr Ile Gly Pro Glu Leu His Lys Ile
275 280 285
Val Lys Glu Pro Gln Ala Tyr Ile Gln Tyr Gln Met Lys Gln Thr Ile
290 295 300
Phe Asp Ser Thr Gly Ile Ser Leu Glu Asp Gln Ile Met Thr Glu Val
305 310 315 320
Leu Ile Asp Gln Ala Glu Arg Leu Gly Leu Gly Gln Arg Ile Leu Ile
325 330 335
Glu Ala Gly Cys Asp Asp Pro Met Asn Pro Tyr Leu Phe Ser Asn Ser
340 345 350
Ala Asn Ala Leu Asp Thr Val Lys Asn Thr Val His Asp Arg Thr Leu
355 360 365
Lys Leu Ala
370
<210> 10
<211> 1116
<212> DNA
<213> Artificial sequence
<400> 10
atggttgctc agcgtgctac catcatcctg tctgaagaaa acatcggtga aatcgttgct 60
gctgttggtc tggacaccct gatggacgaa accatcgcta aactgcgtga cgctctgaac 120
gttttcggtg acggtcaggt tgaaatccag ccgcgtaccg gtttcgttta cgaaaccccg 180
gaaatgggtc tgatcgaatt catgccggct taccgtcgtg acaaaaacgt tgctctgaaa 240
gttgttggtt accacccggg taacccgttc aaccgtggta tgccgaccgt tatcgctacc 300
aactctctgt acgacgttcg tgacggtcac ctgatcgctg ttatcgacgg tgttttcgct 360
accgctgttc gtaccggtgc tgcttctgct gttgcttcta aactgctggc tcacccggaa 420
tctaaaaccc tgggtctgat cggtgctggt gctatggctg ttacccaggc tcacgctctg 480
tctcgtatct acgacttcga cgctgttctg atccacgaca tcgacccggc tgttgaaaaa 540
accttcgcta aacgtgtttc tgctctgggt atcaccccga tcatcgcttc taaagaccgt 600
gttctggctg aatctgacat catctgcgtt gctacctcta tcggtctgga cgctggtccg 660
gttctgcacg ctggtggtat gaaaccgcac gttcacatca acgctatcgg tgctgacacc 720
ccgcgtaaat acgaactgtc taccgaactg ctgaaatctt ctttcctggt taccgactac 780
ctggaacagg ctatcaacga aggtgaatgc cagcagctgt ctaaagacga atacggttac 840
atcggtccgg aactgcacaa aatcgttaaa gaaccgcagg cttacatcca gtaccagatg 900
aaacagacca tcttcgactc taccggtatc tctctggaag accagatcat gaccgaagtt 960
ctgatcgacc aggctgaacg tctgggtctg ggtcagcgta tcctgatcga agctggttgc 1020
gacgacccga tgaacccgta cctgttctct aactctgcta acgctctgga caccgttaaa 1080
aacaccgttc acgaccgtac cctgaaactg gcttaa 1116
<210> 11
<211> 1095
<212> DNA
<213> Streptomyces hirsutus
<400> 11
atgatcttgc aagctgagcg cacgcacatc gtcgacgccg aagccgtcgc caccatcgtc 60
acgaaggtgg gactggggca actctacgac ctgaccatcg cccgcatgga ggcggctctc 120
accggtggac ccggtgcgcc ggtggagatg aagcagcggg acggtttcct gctggagaca 180
ccgcagttgg gcctgctcga gtggatgccg gcggtccgcc aaggcaccac ggtctccatc 240
aagatggtcg cctacaaccc gcacaatccg gtcaagaacc agctgcccac catcctgtcg 300
acactgtgcg ccttcgacac ggacagcggc caccttcgtg ccgtcgtcga cggcacgttc 360
gccaccgccg tccgtacggg cgcggcgtcc gcactggcca gccgggtgct cgctcgcccg 420
gactccgccg tgctcggcct ggtgggctgc ggtgcccagg cggtcacgca gttgcacgcc 480
ctggcacgcg tcttctcgtt ctccgaggtg ctcgtccacg acaaggacgc gcgggcggag 540
cgatccttcg cggcgagggc ccggatgccc gaggggctgg tgcgcgtcgc gccgctcgcg 600
gaggtggagg agcgggccga cgtgctgtgc accgccacct cggtcggccc ccacgagggg 660
ccggtcatcc ggggcacgtc actcaagccc tgggtgcacg tcaacaccat cggatcggac 720
atgccgggca agacggagct gccgctggac cttctgcgcg cggcggtcgt ctgcccggac 780
cacgtggagc aggcacgggc cgagggtgac tgccagcagc tcgcccccga ggagatcggg 840
gctccgctcc ccgacctgct gcgtgatccg gacgcgcacc gcaggctgtc gccggtcacc 900
accgtgtacg actcgacagg tctcgcgctg caggatctcg tcatggtgga ggtgctggag 960
gagttggcgc gggacctcga cgtcggacac cacgtcttca tcgaggcgac ggccgacgac 1020
ccgcaggacc cgtactcgtt cctccctgcg gaggtcaccc ggtccctggc cggcacggcc 1080
ggagcgcgac gatga 1095
<210> 12
<211> 364
<212> PRT
<213> Streptomyces hirsutus
<400> 12
Met Ile Leu Gln Ala Glu Arg Thr His Ile Val Asp Ala Glu Ala Val
1 5 10 15
Ala Thr Ile Val Thr Lys Val Gly Leu Gly Gln Leu Tyr Asp Leu Thr
20 25 30
Ile Ala Arg Met Glu Ala Ala Leu Thr Gly Gly Pro Gly Ala Pro Val
35 40 45
Glu Met Lys Gln Arg Asp Gly Phe Leu Leu Glu Thr Pro Gln Leu Gly
50 55 60
Leu Leu Glu Trp Met Pro Ala Val Arg Gln Gly Thr Thr Val Ser Ile
65 70 75 80
Lys Met Val Ala Tyr Asn Pro His Asn Pro Val Lys Asn Gln Leu Pro
85 90 95
Thr Ile Leu Ser Thr Leu Cys Ala Phe Asp Thr Asp Ser Gly His Leu
100 105 110
Arg Ala Val Val Asp Gly Thr Phe Ala Thr Ala Val Arg Thr Gly Ala
115 120 125
Ala Ser Ala Leu Ala Ser Arg Val Leu Ala Arg Pro Asp Ser Ala Val
130 135 140
Leu Gly Leu Val Gly Cys Gly Ala Gln Ala Val Thr Gln Leu His Ala
145 150 155 160
Leu Ala Arg Val Phe Ser Phe Ser Glu Val Leu Val His Asp Lys Asp
165 170 175
Ala Arg Ala Glu Arg Ser Phe Ala Ala Arg Ala Arg Met Pro Glu Gly
180 185 190
Leu Val Arg Val Ala Pro Leu Ala Glu Val Glu Glu Arg Ala Asp Val
195 200 205
Leu Cys Thr Ala Thr Ser Val Gly Pro His Glu Gly Pro Val Ile Arg
210 215 220
Gly Thr Ser Leu Lys Pro Trp Val His Val Asn Thr Ile Gly Ser Asp
225 230 235 240
Met Pro Gly Lys Thr Glu Leu Pro Leu Asp Leu Leu Arg Ala Ala Val
245 250 255
Val Cys Pro Asp His Val Glu Gln Ala Arg Ala Glu Gly Asp Cys Gln
260 265 270
Gln Leu Ala Pro Glu Glu Ile Gly Ala Pro Leu Pro Asp Leu Leu Arg
275 280 285
Asp Pro Asp Ala His Arg Arg Leu Ser Pro Val Thr Thr Val Tyr Asp
290 295 300
Ser Thr Gly Leu Ala Leu Gln Asp Leu Val Met Val Glu Val Leu Glu
305 310 315 320
Glu Leu Ala Arg Asp Leu Asp Val Gly His His Val Phe Ile Glu Ala
325 330 335
Thr Ala Asp Asp Pro Gln Asp Pro Tyr Ser Phe Leu Pro Ala Glu Val
340 345 350
Thr Arg Ser Leu Ala Gly Thr Ala Gly Ala Arg Arg
355 360
<210> 13
<211> 1095
<212> DNA
<213> Artificial sequence
<400> 13
atgatcctgc aggctgaacg tacccacatc gttgacgctg aagctgttgc taccatcgtt 60
accaaagttg gtctgggtca gctgtacgac ctgaccatcg ctcgtatgga agctgctctg 120
accggtggtc cgggtgctcc ggttgaaatg aaacagcgtg acggtttcct gctggaaacc 180
ccgcagctgg gtctgctgga atggatgccg gctgttcgtc agggtaccac cgtttctatc 240
aaaatggttg cttacaaccc gcacaacccg gttaaaaacc agctgccgac catcctgtct 300
accctgtgcg ctttcgacac cgactctggt cacctgcgtg ctgttgttga cggtaccttc 360
gctaccgctg ttcgtaccgg tgctgcttct gctctggctt ctcgtgttct ggctcgtccg 420
gactctgctg ttctgggtct ggttggttgc ggtgctcagg ctgttaccca gctgcacgct 480
ctggctcgtg ttttctcttt ctctgaagtt ctggttcacg acaaagacgc tcgtgctgaa 540
cgttctttcg ctgctcgtgc tcgtatgccg gaaggtctgg ttcgtgttgc tccgctggct 600
gaagttgaag aacgtgctga cgttctgtgc accgctacct ctgttggtcc gcacgaaggt 660
ccggttatcc gtggtacctc tctgaaaccg tgggttcacg ttaacaccat cggttctgac 720
atgccgggta aaaccgaact gccgctggac ctgctgcgtg ctgctgttgt ttgcccggac 780
cacgttgaac aggctcgtgc tgaaggtgac tgccagcagc tggctccgga agaaatcggt 840
gctccgctgc cggacctgct gcgtgacccg gacgctcacc gtcgtctgtc tccggttacc 900
accgtttacg actctaccgg tctggctctg caggacctgg ttatggttga agttctggaa 960
gaactggctc gtgacctgga cgttggtcac cacgttttca tcgaagctac cgctgacgac 1020
ccgcaggacc cgtactcttt cctgccggct gaagttaccc gttctctggc tggtaccgct 1080
ggtgctcgtc gttaa 1095

Claims (5)

1. A method for synthesizing L-2-piperidinecarboxylic acid by whole-cell biocatalysis is characterized in that L-lysine hydrochloride or L-lysine is used as a substrate, nicotinamide adenine dinucleotide and recombinant host bacteria are added, and L-2-piperidinecarboxylic acid is prepared by biocatalysis; wherein the recombinant host bacterium is a strain containingArenimonasdonghaensisRecombinant host bacterium containing gene encoding DSM 18148 proteinPseudomonas veroniiRecombinant host bacterium containing CIP104663 protein coding gene or recombinant host bacterium containing CIP104663 protein coding geneStreptomyceshirsutusAny one of recombinant host bacteria of ATCC 19091 protein coding gene;
the above-mentionedArenimonasdonghaensisThe DNA sequence of the gene encoding the DSM 18148 protein is SEQ ID NO. 5;
the above-mentionedPseudomonas veroniiThe DNA sequence of the CIP104663 protein coding gene is SEQ ID NO. 10;
the above-mentionedStreptomyceshirsutusThe DNA sequence of the ATCC 19091 protein coding gene is SEQ ID NO. 13;
the recombinant host bacterium is escherichia coli.
2. The method for the whole-cell biocatalytic synthesis of L-2-piperidinecarboxylic acid as claimed in claim 1, wherein the reaction is carried out in a pH8.0 potassium phosphate buffer solution.
3. The method for the whole-cell biocatalytic synthesis of L-2-piperidinecarboxylic acid as claimed in claim 1, wherein the reaction temperature is 20 ℃ to 30 ℃.
4. The method for the whole-cell biocatalytic synthesis of L-2-piperidinecarboxylic acid as claimed in claim 1, wherein the reaction is carried out on a shaker at a rate of 180 rpm.
5. The method for the whole-cell biocatalytic synthesis of L-2-piperidinecarboxylic acid as claimed in claim 1, wherein the concentration of the recombinant host bacteria is 50g/L-150 g/L.
CN201610196785.3A 2016-03-31 2016-03-31 Method for synthesizing L-2-piperidinecarboxylic acid by whole-cell catalysis Active CN107287256B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610196785.3A CN107287256B (en) 2016-03-31 2016-03-31 Method for synthesizing L-2-piperidinecarboxylic acid by whole-cell catalysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610196785.3A CN107287256B (en) 2016-03-31 2016-03-31 Method for synthesizing L-2-piperidinecarboxylic acid by whole-cell catalysis

Publications (2)

Publication Number Publication Date
CN107287256A CN107287256A (en) 2017-10-24
CN107287256B true CN107287256B (en) 2021-06-08

Family

ID=60087599

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610196785.3A Active CN107287256B (en) 2016-03-31 2016-03-31 Method for synthesizing L-2-piperidinecarboxylic acid by whole-cell catalysis

Country Status (1)

Country Link
CN (1) CN107287256B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107641628A (en) * 2016-07-20 2018-01-30 南京诺云生物科技有限公司 The artificial synthesized protein coding genes of Arenimonas donghaensisi DSM 18418 and its application
CN109735553B (en) * 2018-12-29 2022-07-12 南京诺云生物科技有限公司 Preparation method of anti-AIDS drug atazanavir intermediate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106591387A (en) * 2016-12-21 2017-04-26 南京工业大学 Method for synthesizing pipecolic acid through one-step enzymatic catalysis based on microchannel reactor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2825717B1 (en) * 2001-06-08 2005-02-18 Rhodia Chimie Sa STEREOSELECTIVE PREPARATION OF CYCLIC AMINO ACIDS
WO2008067981A2 (en) * 2006-12-04 2008-06-12 Dsm Ip Assets B.V. Whole-cell catalytic system comprising a hydantoinase, a racemase and a carbamoylase
CN102154384B (en) * 2011-01-19 2013-03-06 山东大学 Method for producing chiral pure (2S,3S)-2,3-butanediol
GB201411177D0 (en) * 2014-06-24 2014-08-06 Univ Cape Town Method of biotransforma of linear alkanes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106591387A (en) * 2016-12-21 2017-04-26 南京工业大学 Method for synthesizing pipecolic acid through one-step enzymatic catalysis based on microchannel reactor

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
cyclodeaminase [Streptomyces sp.L-49973],Accession:CBL93715.1;Binz T.M et al.;《GenBank》;20101021;第1页 *
ornithine cyclodeaminase [Pseudomonas veronii],Accession:WP_046382765.1;GenBank;《GenBank》;20150423;第1页 *

Also Published As

Publication number Publication date
CN107287256A (en) 2017-10-24

Similar Documents

Publication Publication Date Title
CN108220276B (en) Cephalosporin C acylase mutant and application thereof in 7-aminocephalosporanic acid production
CN109735553B (en) Preparation method of anti-AIDS drug atazanavir intermediate
CN112143764B (en) Method for preparing intermediate compound of brivaracetam by using biological enzyme catalysis
CN109504645B (en) Isoleucine dioxygenase, mutant and application in synthesis of 4-hydroxyisoleucine
CN112126610A (en) Engineering bacterium for producing hydroxytyrosol
CN107287256B (en) Method for synthesizing L-2-piperidinecarboxylic acid by whole-cell catalysis
CN113355367B (en) Application of ketoacid reductase in synthesis of chiral aromatic 2-hydroxy acid
CN115960736B (en) Saccharomyces cerevisiae engineering bacteria for producing vanillyl amine and capsaicin, construction method and application thereof
CN114891707B (en) Recombinant strain and method for producing bilirubin by whole cell catalysis thereof
CN109943577B (en) Biotransformation method of anti-AIDS drug atazanavir intermediate
CN109055417B (en) Recombinant microorganism, preparation method thereof and application thereof in production of coenzyme Q10
CN114908129B (en) Dehydrogenase for the preparation of (R) -4-chloro-3-hydroxybutyric acid ethyl ester
KR102011415B1 (en) Novel CO2 reductase from Rhodobacter aestuarii and thereof
CN111254170B (en) Method for preparing (S) -1,2,3, 4-tetrahydroisoquinoline-3-formic acid by multienzyme coupling
CN110835639B (en) Method for preparing (S) -1,2,3, 4-tetrahydroisoquinoline-1-formic acid and derivatives thereof
CN109609522B (en) Macleaya cordata dihydrobenzophenanthridine oxidase gene optimization sequence and application thereof
CN112760298A (en) Cytochrome P450BM3 oxidase mutant and preparation method and application thereof
CN107286227B (en) Novel use of Streptomyces hirsutus ATCC 19091 protein
CN114262681B (en) Berberine production strain, establishment method and application thereof
CN107287215B (en) Artificially synthesized Streptomyces hirsutus ATCC 19091 protein coding gene and application thereof
CN114317631B (en) Application of monoamine oxidase in preparation of topiroxone
CN112592913B (en) Thermally stable threonine deaminase and application thereof
WO2023106543A1 (en) Corynebacterium glutamicum variant having improved l-lysine production ability and method for producing l-lysine by using same
CN109609521B (en) Optimized sequence of macleaya cordata protopine-6-hydroxylase gene and application thereof
CN107287173B (en) Thymidine phosphorylase protein mutant

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant